医薬品のヨーロッパ市場2021-2028:製品別(ブランド別、ジェネリック)、種類別(処方箋、OTC)、治療カテゴリー別、地域別

調査会社Grand View Research社が発行したリサーチレポート(データ管理コード:GV21OT064)
◆英語タイトル:Europe Pharmaceutical Market Size, Share & Trends Analysis Report By Product (Branded, Generic), By Type (Prescription, OTC), By Therapeutic Category, By Region, And Segment Forecasts, 2021 - 2028
◆発行会社/調査会社:Grand View Research
◆商品コード:GV21OT064
◆発行日:2021年10月12日
◆調査対象地域:ヨーロッパ
◆産業分野:医薬品
◆ページ数:190
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(3営業日)
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥799,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,029,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[医薬品のヨーロッパ市場2021-2028:製品別(ブランド別、ジェネリック)、種類別(処方箋、OTC)、治療カテゴリー別、地域別]についてメールでお問い合わせはこちら
グランドビューリサーチ社は、医薬品のヨーロッパ市場規模が2028年までに4,321.2億ドルに達すると予測しています。2021年から2028年までの間に年平均5.4%成長する見通しです。本調査資料は、ヨーロッパの医薬品市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品別分析、種類別分析、治療カテゴリー別分析、地域別分析、競争状況などの項目を掲載しています。
*** レポート概要(サマリー)***

Europe Pharmaceutical Market Growth & Trends
The Europe pharmaceutical market size is expected to reach USD 432.12 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.4% from 2021 to 2028. The market is driven by an increasing prevalence of diseases, a growing elderly population, and the approval and launch of novel products in the European region.

Overall, the pharmaceutical market in Europe is dominated by branded drugs; however, the generic drugs segment is anticipated to grow at the fastest rate over the forecast period. Loss of patent protection of key pharmaceutical products and increasing government initiatives to adopt generic drugs for the treatment are some of the key factors likely to boost generics demand in the coming years.

The capitalization opportunity is high for generic manufacturers in the European market as governments from each region are forming plans to meet the population’s demand and lower healthcare-associated expenditure of the country. The expiration of patent exclusivities and the building need for cost-effective treatments are fueling the penetration of biosimilars and generics.

Novel molecule entry in this market typically takes 12-13 years and an investment of over USD 2.5 billion. In 2019, the total R&D expenditure on pharmaceutical R&D was USD 44,881.92 million. Increased competition from growing economies, such as China and Brazil, has accelerated the European economic investment in research to maintain its dominance in the market.

Improvements in healthcare infrastructure are promoting the adoption of novel pharmaceuticals. Furthermore, an increase in drug launches in Europe is projected to propel the market growth. For instance, in 2020, 62 drugs were approved in Europe and 97 medicines received marketing approval in European countries. The highest number of drug approvals were observed in the oncology segment.

Key pharmaceutical companies offer strong branded drugs in multiple therapeutic segments. Increasing R&D efforts, the growing adoption of novel therapies, and strategic collaborations are likely to boost the penetration of branded drugs. Strong pipeline products in different therapeutic areas are likely to fuel the growth of branded drugs in Europe.

Europe Pharmaceutical Market Report Highlights

• By therapeutic category, the oncology segment is expected to grow at the fastest rate owing to the increasing prevalence of cancer along with the entry of novel molecules into the market

• Based on product, generic drugs are expected to emerge as the fastest-growing segment over the forecast period owing to the increased preference of the consumers for generic drugs due to their cost-effectiveness

• In terms of type, the prescription segment held the largest share in 2020 owing to the presence of the majority of pharmaceuticals in the prescription category

• Western Europe held the largest share in 2020 owing to the presence of countries with developed healthcare systems

• The preference of companies for contract manufacturing is rising in Europe due to the specialized nature of pharmaceutical products and reasonable production costs

*** レポート目次(コンテンツ)***

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Type
1.1.3 Therapeutic Category
1.1.4 Regional Scope
1.1.5 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Insights
2.3 Competitive Insights
Chapter 3 Europe Pharmaceuticals Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.4 Regulatory Framework
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Growing prevalence of diseases
3.5.1.2Growing geriatric population
3.5.1.3Approval and launch of new drugs
3.5.1.4 Increasing healthcare expenditure
3.5.1.5 Emergence of biologics and biologics
3.5.1.6 Entry of new technologies in supply chain and production
3.5.2 Market restraint analysis
3.5.2.1 Patent expirations and increasing generic penetration
3.5.2.2 Pricing pressure
3.5.2.3 Impact of COVID-19
3.5.2.4 Reduced demand for prescription medicines for common ailments
3.5.2.5 Adverse effects of drugs
3.5.2.6 Competition from complementary and alternative medicine
3.5.3 Industry challenges
3.5.3.1 Presence of ambiguous regulatory framework
3.6 Europe Pharmaceuticals Market Analysis Tools
3.6.1 Industry analysis – Porter’s
3.6.2 PESTLE Analysis
3.6.3 Major deals and strategic alliances analysis
3.6.3.1 New product launch
3.6.3.2 Mergers and acquisitions
3.6.3.3 Expansion
3.6.3.4 Partnerships
3.6.3.5 Marketing & promotions
3.6.4 Market entry strategies
Chapter 4 Europe Pharmaceuticals Market – Segment Analysis, By Product, 2017 – 2028 (USD Billion)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2020&2028
4.3 Segment Dashboard
4.4 Europe Pharmaceuticals Market, by Product, 2017 to 2028
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
4.5.1 Branded
4.5.1.1 Branded market estimates and forecast, 2017 – 2028 (USD Billion)
4.5.2 Generic
4.5.2.1 Generic market estimates and forecast, 2017 – 2028 (USD Billion)
Chapter 5 Europe Pharmaceuticals Market – Segment Analysis, By Type, 2017 – 2028 (USD Billion)
5.1 Definition and Scope
5.2 Type Market Share Analysis, 2020&2028
5.3 Segment Dashboard
5.4 Europe Pharmaceuticals Market, by Type, 2017 to 2028
5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
5.5.1 OTC
5.5.1.1 OTC market estimates and forecast, 2017 – 2028 (USD Billion)
5.5.2 Prescription
5.5.2.1 Prescription market estimates and forecast, 2017 – 2028 (USD Billion)
Chapter 6 Europe Pharmaceuticals Market – Segment Analysis, By Therapeutic Category, 2017 – 2028 (USD Billion)
6.1 Definition and Scope
6.2 Therapeutic Category Market Share Analysis, 2020&2028
6.3 Segment Dashboard
6.4 Europe Pharmaceuticals Market, by Therapeutic Category, 2017 to 2028
6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
6.5.1 Oncology
6.5.1.1 Oncology market estimates and forecast, 2017 – 2028 (USD Billion)
6.5.2 Cardiovascular diseases
6.5.2.1 Cardiovascular diseases market estimates and forecast, 2017 – 2028 (USD Billion)
6.5.3 Anti-infectives
6.5.3.1 Anti-infectives market estimates and forecast, 2017 – 2028 (USD Billion)
6.5.4 Central Nervous System Disorders
6.5.4.1 Central nervous system disorders market estimates and forecast, 2017 – 2028 (USD Billion)
6.5.5 Metabolic Disorders
6.5.5.1 Metabolic disorders market estimates and forecast, 2017 – 2028 (USD Billion)
6.5.6 Gastrointestinal Disorders
6.5.6.1 Gastrointestinal disorders market estimates and forecast, 2017 – 2028 (USD Billion)
6.5.7 Respiratory Diseases
6.5.7.1 Respiratory diseases market estimates and forecast, 2017 – 2028 (USD Billion)
6.5.7 Other Disorders
6.5.7.1 Other Disorders market estimates and forecast, 2017 – 2028 (USD Billion)
Chapter 7 Europe Pharmaceuticals Market – Segment Analysis, By Region, 2017 – 2028 (USD Billion)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2020&2028
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Regional Market Share and Leading Players, 2020
7.5.1 Western Europe
7.5.2 Central and Eastern Europe
7.5.3 Nordic Regions
7.5.4 Rest of Europe
7.6 SWOT Analysis
7.6.1 Western Europe
7.6.2 Central and Eastern Europe
7.6.3 Nordic Regions
7.6.4 Rest of Europe
7.7 Market Size, & Forecasts, Revenue and Trend Analysis, 2020 to 2028
7.7.1 Western Europe
7.7.1.1 Western Europe market estimates and forecast, 2017-2028 (USD Billion)
7.7.1.2 U.K.
7.7.1.2.1 U.K. Pharmaceuticals market estimates and forecast, 2017 – 2028 (USD Billion)
7.7.1.3 Germany
7.7.1.3.1 Germany Pharmaceuticals market estimates and forecast, 2017 – 2028 (USD Billion)
7.7.1.4 France
7.7.1.4.1 France Pharmaceuticals market estimates and forecast, 2017 – 2028 (USD Billion)
7.7.1.5 Spain
7.7.1.5.1 Spain Pharmaceuticals market estimates and forecast, 2017 – 2028 (USD Billion)
7.7.1.6 Italy
7.7.1.6.1 Italy Pharmaceuticals market estimates and forecast, 2017 – 2028 (USD Billion)
7.7.2 Central and Eastern Europe
7.7.2.1 Central and Eastern Europe market estimates and forecast, 2017-2028 (USD Billion)
7.7.2.2 Poland
7.7.2.2.1 Poland Pharmaceuticals market estimates and forecast, 2017 – 2028 (USD Billion)
7.7.2.3 Hungary
7.7.2.3.1 Hungary Pharmaceuticals market estimates and forecast, 2017 – 2028 (USD Billion)
7.7.2.4 Switzerland
7.7.2.4.1 Switzerland Pharmaceuticals market estimates and forecast, 2017 – 2028 (USD Billion)
7.7.3 Nordic Regions
7.7.3.1 Nordic regions market estimates and forecast estimates and forecast, 2017-2028 (USD Billion)
7.7.3.2 Denmark
7.7.3.2.1 Denmark Pharmaceuticals market estimates and forecast, 2017 – 2028 (USD Billion)
7.7.3.3 Finland
7.7.3.3.1 Finland Pharmaceuticals market estimates and forecast, 2017 – 2028 (USD Billion)
7.7.3.4 Norway
7.7.3.4.1 Norway Pharmaceuticals market estimates and forecast, 2017 – 2028 (USD Billion)
7.7.4 Rest of Europe
7.7.4.1 Rest of Europe market estimates and forecast estimates and forecast, 2017-2028 (USD Billion)
Chapter 8 COMPETITIVE LANDSCAPE
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.1.1 Ansoff matrix
8.1.2 Heat map analysis
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List of key distributors and channel partners
8.3.2 Key customers
8.3.3 Key company market share analysis, 2020
8.4 Public Companies
8.4.1 Company market position analysis
8.4.2 Company Market Share, by region, 2020
8.4.3 Competitive Dashboard Analysis
8.4.3.1 Market Differentiators
8.5 Private Companies
8.5.1 List of key emerging companies
8.6 Company Profiles
8.6.1 F. Hoffmann-La Roche Ltd.
8.6.1.1 Company Overview
8.6.1.2 Financial Performance
8.6.1.3 Product benchmarking
8.6.1.4 Strategic initiatives
8.6.2 Bristol-Myers Squibb Company
8.6.2.1 Company overview
8.6.2.2 Financial Performance
8.6.2.3 Product benchmarking
8.6.2.4 Strategic initiatives
8.6.3 AstraZeneca plc
8.6.3.1 Company Overview
8.6.3.2 Financial Performance
8.6.3.3 Product Benchmarking
8.6.3.4 Strategic Initiatives
8.6.4 Novartis AG
8.6.4.1 Company Overview
8.6.4.2 Financial Performance
8.6.4.3 Product Benchmarking
8.6.4.4 Strategic Initiatives
8.6.5 Johnson & Johnson Services, Inc.
8.6.5.1 Company Overview
8.6.5.2 Financial Performance
8.6.5.3 Product Benchmarking
8.6.5.4 Strategic Initiatives
8.6.6 Gilead Sciences, Inc.
8.6.6.1 Company Overview
8.6.6.2 Financial Performance
8.6.6.3 Product Benchmarking
8.6.6.4 Strategic Initiatives
8.6.7 GlaxoSmithKline plc.
8.6.7.1 Company Overview
8.6.7.2 Financial Performance
8.6.7.3 Product Benchmarking
8.6.7.4 Strategic Initiatives
8.6.8 Merck & Co., Inc.
8.6.8.1 Company Overview
8.6.8.2 Financial Performance
8.6.8.3 Product Benchmarking
8.6.8.4 Strategic Initiatives
8.6.9 Pfizer Inc.
8.6.9.1 Company Overview
8.6.9.2 Financial Performance
8.6.9.3 Product Benchmarking
8.6.9.4 Strategic Initiatives
8.6.10 Sanofi
8.6.10.1 Company Overview
8.6.10.2 Financial Performance
8.6.10.3 Product Benchmarking
8.6.10.4 Strategic Initiatives
8.6.11 Boehringer Ingelheim GmbH
8.6.11.1 Company Overview
8.6.11.2 Financial Performance
8.6.11.3 Product Benchmarking
8.6.11.4 Strategic Initiatives

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Europe Pharmaceuticals Market, By Region, 2017 - 2028 (USD Billion)
TABLE 5 Europe Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 6 Europe Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 7 Europe Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 8 Western Europe Pharmaceuticals Market, By Country, 2017 - 2028 (USD Billion)
TABLE 9 Western Europe Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 10 Western Europe Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 11 Western Europe Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 12 U.K. Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 13 U.K. Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 14 U.K. Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 15 Germany Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 16 Germany Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 17 Germany Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 18 France Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 19 France Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 20 France Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 21 Spain Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 22 Spain Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 23 Spain Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 24 Italy Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 25 Italy Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 26 Italy Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 27 Central and Eastern Europe Pharmaceuticals Market, By Country, 2017 - 2028 (USD Billion)
TABLE 28 Central and Eastern Europe Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 29 Central and Eastern Europe Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 30 Central and Eastern Europe Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 31 Poland Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 32 Poland Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 33 Poland Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 34 Hungary Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 35 Hungary Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 36 Hungary Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 37 Switzerland Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 38 Switzerland Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 39 Switzerland Pharmaceuticals Market, By Application, 2017 - 2028 (USD Billion)
TABLE 40 Nordic Regions Pharmaceuticals Market, By Country, 2017 - 2028 (USD Billion)
TABLE 41 Nordic Regions Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 42 Nordic Regions Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 43 Nordic Regions Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 44 Denmark Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 45 Denmark Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 46 Denmark Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 47 Finland Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 48 Finland Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 49 Finland Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 50 Norway Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 51 Norway Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 52 Norway Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)
TABLE 53 Rest of Europe Pharmaceuticals Market, By Product, 2017 - 2028 (USD Billion)
TABLE 54 Rest of Europe Pharmaceuticals Market, By Type, 2017 - 2028 (USD Billion)
TABLE 55 Rest of Europe Pharmaceuticals Market, By Therapeutic Category, 2017 - 2028 (USD Billion)


List of Figures

FIG. 1 Europe Pharmaceuticals market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Primary interviews in Europe
FIG. 6 Market research approaches
FIG. 7 Value-chain-based sizing & forecasting
FIG. 8 QFD modeling for market share assessment
FIG. 9 Market formulation & validation
FIG. 10 Europe pharmaceuticals market snapshot
FIG. 11 Segment Insights
FIG. 12 Strategy framework
FIG. 13 Penetration & growth prospect mapping
FIG. 14 Consumer behavior analysis
FIG. 15 Market driver relevance analysis (Current & future impact)
FIG. 16 Market restraint relevance analysis (Current & future impact)
FIG. 17 Porter’s five forces analysis
FIG. 18 PESTLE analysis
FIG. 19 Strategy mapping
FIG. 20 Europe pharmaceuticals market: Product movement analysis
FIG. 21 Product segment dashboard
FIG. 22 Europe pharmaceuticals market product outlook: Key takeaways
FIG. 23 Branded market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 24 Generic market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 25 Europe pharmaceuticals market: Type movement analysis
FIG. 26 Type segment dashboard
FIG. 27 OTC pharmaceuticals market type outlook: Key takeaways
FIG. 28 Prescription market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 29 Europe pharmaceuticals market: therapeutic category movement analysis
FIG. 30 Therapeutic category segment dashboard
FIG. 31 Europe pharmaceuticals market therapeutic category outlook: Key takeaways
FIG. 32 Oncology market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 33 Cardiovascular diseases market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 34 Anti-infectives market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 35 Central nervous system disorders market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 36 Metabolic disorders market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 37 Gastrointestinal disorders market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 38 Respiratory diseases estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 39 Other Disorders estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 40 Regional outlook, 2020&2028
FIG. 41 Regional market dashboard
FIG. 42 Regional marketplace: Key takeaways
FIG. 43 Western Europe market share and leading players, 2020
FIG. 44 Central and Eastern Europe market share and leading players, 2020
FIG. 45 Nordic regions market share and leading players, 2020
FIG. 46 Rest of Europe market share and leading players, 2020
FIG. 47 Western Europe
FIG. 48 Western Europe pharmaceuticals market, 2017 - 2028 (USD Billion)
FIG. 49 U.K.
FIG. 50 U.K. pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 51 Germany
FIG. 52 Germany pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 53 France
FIG. 54 France pharmaceuticals market, 2017 - 2028 (USD Billion)
FIG. 55 Spain
FIG. 56 Spain pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 57 Italy
FIG. 58 Italy pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 59 Central and Eastern Europe
FIG. 60 Central and Eastern Europe pharmaceuticals market estimates and forecast, 2017 - 2028(USD Billion)
FIG. 61 Poland
FIG. 62 Poland pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 63 Hungary
FIG. 64 Hungary pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 65 Switzerland
FIG. 66 Switzerland pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 67 Nordic Regions
FIG. 68 Nordic regions pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 69 Denmark
FIG. 70 Denmark pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 71 Finland
FIG. 72 Finland pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 73 Norway
FIG. 74 Norway Europe pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 75 Rest of Europe
FIG. 76 Rest of Europe pharmaceuticals market estimates and forecast, 2017 - 2028 (USD Billion)
FIG. 77 Ansoff Matrix
FIG. 78 Heat map analysis
FIG. 79 Company market share analysis
FIG. 80 Company market position analysis
FIG. 81 Company market share, by region, 2020
FIG. 82 Market differentiators

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • プラスチック殺生物剤の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Plastic Biocides Revenue, means the sales value of Plastic Biocides This report studies sales (consumption) of Plastic Biocides in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales …
  • チューブレスタイヤの世界市場 2019年-2023年
    In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Tubeless Tire Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional m …
  • 光ファイバケーブル用ポリブチレンテレフタレート樹脂の世界及び中国市場 2018年
    The 'Global and Chinese PBT Resin for Optical Fiber Cable Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global PBT Resin for Optical Fiber Cable industry with a focus on the Chinese market. The report provides key statistics on the marke …
  • 新型コロナウイルス感染症ワクチンのインド市場2021-2027
    India's COVID-19 vaccines market is anticipated to grow over US$ 2.3 Billion by 2027 with an impressive CAGR of more than 25% during the forecast period. The prominent factors that are expected to contribute to the growth of the Indian COVID-19 vaccines market during the forecast period: • Approval/ …
  • アルゼンチンの整形外科手術用動力機器市場見通し
    Argentina Orthopedic Power Tools Market Outlook to 2022 Summary GlobalData’s new report, Argentina Orthopedic Power Tools Market Outlook to 2022, provides key market data on the Argentina Orthopedic Power Tools market. Note: This is an on-demand report and will be delivered within 2-3 business days …
  • 酸化マグネシウム防火ボードの世界市場
    In this report, the global Magnesium Oxide Anti-Fire Boards market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), …
  • 世界のモバイルペイメント市場予測2021年-2026年
    The global mobile payments market reached a value of US$ 1.43 Billion in 2020. As per the estimates by IMARC Group, the market is anticipated to witness strong growth during the forecast period (2021-2026). Mobile payment refers to an automated payment method that is made under financial supervision …
  • ヒストンデアセチラーゼ1(HDAC8)阻害剤のパイプライン・インサイト2019
    SUMMARY DelveInsight’s, “Histone Deacetylase 1 (HDAC8) Inhibitors-Pipeline Insights, 2019”, report provides in depth insights on the pipeline drugs and their development activities around the Histone Deacetylase 1 (HDAC8) Inhibitors. The DelveInsight’s Report covers the product profiles in various s …
  • 世界の路面標示用塗料市場予測 2021年-2026年
    According to this latest study, the 2021 growth of Road Marking Paint will have significant change from previous year. By the most conservative estimates of global Road Marking Paint market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2733.6 millio …
  • 振動フィーダーの世界市場インサイト2020:企業別、地域別、用途別
    This report describes the global market size of Vibratory Feeder from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 2015 to 2025 …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GV21OT064 )"医薬品のヨーロッパ市場2021-2028:製品別(ブランド別、ジェネリック)、種類別(処方箋、OTC)、治療カテゴリー別、地域別" (英文:Europe Pharmaceutical Market Size, Share & Trends Analysis Report By Product (Branded, Generic), By Type (Prescription, OTC), By Therapeutic Category, By Region, And Segment Forecasts, 2021 - 2028)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。